ResourcesGuide

Are Wall Street Analyst Ratings Biased?

The evidence on analyst optimism, where the conflicts come from, what regulation changed, and how to correct for the bias when you read a rating.

Published Updated 7 min readHow we research

Key takeaways

  • Yes, on average analyst ratings lean optimistic: 70.4% of recent ratings in Exent’s data were Buy and 3.0% Sell, and the average analyst’s price targets reached their level within 12 months only 53.0% of the time.
  • The bias has known sources: investment banking ties, access to management, trading revenue, career incentives and analysts choosing which stocks to cover.
  • Academic studies found affiliated analysts’ buys did worse than independent ones, and that target prices implied higher returns than stocks delivered.
  • Bias is not the same as uselessness. Ratings changes still carry information, and accuracy varies widely from one analyst to the next.

Which stocks do Wall Street’s best‑ranked analysts agree on? See them in Exent Gems →

Are analyst ratings biased?

Yes, on average they lean bullish. The clearest sign is the rating mix: buys outnumber sells by about 24 to 1 in Exent’s data. The second sign is price targets, which are set above the current price most of the time and are reached only about half the time.

Measure (Exent’s 7-year backtest)Value
Ratings analysed988,127 from the 1,191 analysts in Exent’s ranking
Buy / Hold / Sell, last 12 months70.4% / 26.6% / 3.0%
Price targets reached within 12 months (average analyst)53.0%, across 820,838 calls with a target
Average implied upside when the target was set66.0%
Median 12-month price return after a call+13.6%

Statistics as of Nov 16, 2026. The implied upside is an average, so a minority of very large targets pulls it up; the gap to realized returns is still wide. Our study of how accurate price targets are breaks these numbers down.

Where does analyst bias come from?

Sell-side analysts work for banks and brokers whose revenue does not come from the accuracy of the research itself. Five pressures follow from that.

PressureHow it tilts ratings
Investment bankingFirms want to win the company’s deals; a negative rating does not help
Management accessAnalysts rely on company calls and meetings that a harsh view can jeopardize
Trading revenueBuy ideas generate more client trading than sell ideas
Career incentivesOptimism has been linked to better job moves
Coverage choiceAnalysts pick up stocks they like and drop the rest quietly

The difference between who pays and who reads is covered in sell-side vs buy-side.

What evidence is there of optimism bias?

A long line of research documents it. Some of the most cited findings:

  • Underwriting conflicts. Michaely and Womack (1999) found that stocks recommended by analysts whose firm had underwritten the company’s IPO performed worse than buy recommendations from unaffiliated brokers, and that the market did not fully see the bias.
  • Career rewards. Hong and Kubik (2003) found that, holding accuracy constant, analysts who were optimistic relative to the consensus were more likely to move to better firms.
  • Inflated targets. Brav and Lehavy (2003) found the average one-year target was 28% above the current price in 1997–1999. Bradshaw, Brown and Huang (2013) found that target-implied returns exceeded actual returns by 15% on average for 2000–2009 targets.

Bank disclosures show the link to banking business directly. In J.P. Morgan’s ratings disclosure as of June 30, 2014, 75% of the US broker’s Overweight-rated companies had been investment banking clients in the prior 12 months, against 54% of its Underweight-rated ones. That does not prove any single rating was biased. It shows why rules require the disclosure.

What did regulators do about analyst conflicts?

They forced a wall between research and banking. In 2003, ten firms settled with the SEC, NASD, NYSE and state regulators for roughly $1.4 billion in the Global Research Analyst Settlement, without admitting or denying the allegations. Two star analysts were barred for life: Henry Blodget, who paid $4 million, and Jack Grubman, who paid $15 million.

Today FINRA Rule 2241 bars paying analysts for specific banking deals, stops bankers from supervising analysts, and requires each report to disclose the firm’s buy, hold and sell distribution. The rules reduced the most blatant conflicts. The rating mix in the same data shows the optimistic tilt remains.

If ratings are biased, are they useless?

No. A biased signal can still be informative if you know the direction of the bias. Two findings matter most. First, changes carry more information than levels: an upgrade or downgrade says more than a standing buy. Second, analysts differ enormously. In the same data, 56 ranked analysts had price-target hit rates of 80% or more, while 99 were below 30%.

So the practical fix is not to ignore analysts. It is to discount the average and weight the individual by track record. See how to judge an analyst and the most accurate stock analysts study.

Exent’s top 50 analysts

Across 988,127 ratings, the average Wall Street analyst’s price target was reached 53.0% of the time: close to a coin flip. The spread between analysts is wide, and 14.4% of the 971 analysts with a measurable record reached 70% or more (Exent data, Nov 16, 2026).

Exent Gems is built on the top 50 of Exent’s ranking. Over the last two years, some of them reached 90% or more of their price targets. Who they are, which stocks they are calling now and how often they have been right is for members.

How can you adjust for analyst bias?

  • Treat a Hold as cautious and a Sell as a strong statement, since sells are rare.
  • Shrink price-target upside in your head: on average targets implied more than stocks delivered.
  • Prefer changes (upgrades, downgrades, target cuts) over static ratings.
  • Check the disclosure section for banking relationships with the company.
  • Weight analysts by their own past accuracy, not by the bank’s name.

Public analyst rankings that score analysts on how their past calls played out make the last point practical. Related: why analysts rarely say sell.

How to weight analysts by accuracy with Exent

  1. Stocks Radar tracks thousands of Wall Street analysts and ranks them by past accuracy; each profile shows hit rate, star rating, price targets and covered stocks.
  2. Gems are stocks where several top‑rated analysts (4★ and above) agree: Exent’s hunt for the next big winners, not a forecast.
  3. Upload your holdings to Portfolio Analysis to see what analysts and insiders say about the stocks you already own.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

Yes. In Exent’s data, 70.4% of ratings issued in the 12 months to Nov 16, 2026 were Buy and only 3.0% were Sell.

Targets reflect the same optimism as ratings. Research on 2000 to 2009 targets found target-implied returns exceeded actual returns by 15% on average, and Exent’s data shows the average analyst’s targets were reached within 12 months only 53.0% of the time.

It reduced the most direct conflicts by separating research from investment banking and requiring disclosures. Ratings still lean heavily toward buy.

They lack investment banking conflicts, and a 1999 study found affiliated analysts’ buy calls on IPOs did worse than those of unaffiliated brokers. Independence removes one source of bias, not all of them.

Look at the analyst’s own record: how often past price targets were reached, how often stocks rose after their calls, and over how many calls. Accuracy varies widely between analysts.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.